XERS Operating Income Growth
Xeris Biopharma Holdings Inc · Operating Income Growth
XERS Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported472.56%period ending
XERS TTM Operating Income YoY % (-122.85% → 472.56%)
Year-over-year change
High-resolution chart · PNG
XERS operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| 472.5616% | |
| 259.6283% | |
| 173.9939% | |
| 121.7022% | |
| 73.5868% | |
| 49.9956% | |
| 23.5492% | |
| 8.4578% | |
| 41.167% | |
| 31.9989% | |
| 46.29% | |
| 57.1118% | |
| 47.5986% | |
| 48.1191% | |
| 28.8444% | |
| -33.4149% | |
| -59.5194% | |
| -76.9908% | |
| -37.8354% | |
| 11.1088% | |
| 33.2869% | |
| 42.4651% | |
| 31.7323% | |
| 11.7287% | |
| -19.6171% | |
| -71.383% | |
| -106.2214% | |
| -127.8094% | |
| -131.8538% | |
| -116.7042% | |
| -122.8548% |